260 related articles for article (PubMed ID: 12234290)
1. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H; Iida M
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii9-12. PubMed ID: 12771291
[TBL] [Abstract][Full Text] [Related]
3. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
Buchwald PC; Akerström G; Westin G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
[TBL] [Abstract][Full Text] [Related]
4. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.
Taniguchi M; Tokumoto M; Matsuo D; Motoyama K; Sugitani A; Kuroki S; Yotsueda H; Tsuruya K; Hirakata H; Iida M
Kidney Int; 2006 Jul; 70(2):363-70. PubMed ID: 16738533
[TBL] [Abstract][Full Text] [Related]
5. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
Tominaga Y; Matsuoka S; Sato T; Uno N; Goto N; Katayama A; Haba T;
Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
[TBL] [Abstract][Full Text] [Related]
7. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
[TBL] [Abstract][Full Text] [Related]
10. 22-Oxacalcitriol upregulates p21(WAF1/Cip1) in human parathyroid glands. A preliminary report.
Shiraishi K; Tsuchida M; Wada T; Yoshihiro S; Takai K; Suga A; Kaneda Y; Naito K
Am J Nephrol; 2001; 21(6):507-11. PubMed ID: 11799271
[TBL] [Abstract][Full Text] [Related]
11. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
14. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
17. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
[No Abstract] [Full Text] [Related]
18. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism.
Matsuoka S; Tominaga Y; Sato T; Uno N; Hiramitu T; Goto N; Nagasaka T; Uchida K
Ther Apher Dial; 2008 Oct; 12(5):391-5. PubMed ID: 18937723
[TBL] [Abstract][Full Text] [Related]
20. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]